CR MEDICAL (01515) announced its annual performance, with a net profit attributable to shareholders of 4.96 billion yuan, a decrease of 12.36% year-on-year.

CR MEDICAL (01515) announced its annual performance for the year ending December 31, 2025. The group achieved a revenue of RMB 9.176 billion, a decrease of 6.9% compared to the previous year. The net profit attributable to owners of the company was RMB 496 million, a decrease of 12.36% year-on-year. The earnings per share were RMB 0.39, with a proposed final dividend of RMB 0.084 per share. During the reporting period, the revenue of the hospital business segment was RMB 8.675 billion, a decrease of 5.5% compared to the previous year. Outpatient visits increased by 3.4%, while inpatient visits decreased by 2.7%. Due to the impact of medical insurance cost control, both outpatient and inpatient revenue per visit decreased by 6.6% and 4.9%, respectively. Efforts were made during the reporting period to mitigate the impact of declining revenue per visit on the hospital business segment's profit by improving quality, efficiency, and reducing costs. The gross profit of the hospital business segment was RMB 1.367 billion, a decrease of 17.3% year-on-year, with a gross profit margin of 15.8%. The performance of the hospital business segment was approximately RMB 500 million, a decrease of 34.7% year-on-year, mainly due to the decrease in average expenses.